Cantor Fitzgerald maintains a 'Buy' on ImmunoGen, Inc. (Nasdaq: IMGN). Price target increased from $8 to $12.

This article: 125 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE